Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 20/20 | 0.76 |
| ▸ | ERBB2 | P04626 | 19/20 | 0.76 |
| ▸ | ERBB3 | P21860 | 17/20 | 0.76 |
| ▸ | ERBB4 | Q15303 | 17/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2747143 | 0.89 | EGFR (0.81) | EGFRERBB2ERBB3ERBB4 | |
| SCHEMBL4544801 | 0.89 | EGFR (0.93) | EGFRERBB2ERBB3ERBB4 | |
| Hydrochloric Acid SCHEMBL2749070 | 0.88 | EGFR (0.91) | EGFRERBB2ERBB3ERBB4 | |
| SCHEMBL2748571 | 0.86 | EGFR (1.00) | EGFRERBB2ERBB3ERBB4 | |
| SCHEMBL3505219 | 0.86 | EGFR (0.79) | EGFRERBB2ERBB3ERBB4 | |
| SCHEMBL3506298 | 0.86 | EGFR (0.86) | EGFRERBB2ERBB3ERBB4 | |
| SCHEMBL14494850 | 0.86 | EGFR (0.86) | EGFRERBB2ERBB3ERBB4 | |
| SCHEMBL3506623 | 0.86 | EGFR (0.87) | EGFRERBB2ERBB3ERBB4 | |
| Hydrochloric Acid SCHEMBL3506386 | 0.85 | EGFR (0.85) | EGFRERBB2ERBB3ERBB4 | |
| SCHEMBL986656 | 0.85 | EGFR (1.00) | EGFRERBB2ERBB3ERBB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010036928-A1 | PREVENTION AND TREATMENT OF CANCER WITH LKB1 NON-EXPRESSION (DELETION OR MUTATION) | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-04-01 | — | — | WO | disclosed |